5. July 2022
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra name in the future.
26. April 2022
One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business ambitions and our roots in one of the country’s most important pharmaceutical hubs.
14. April 2022
Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further legalization.
6. April 2022
Eurox Group raises €4.4M at a significant premium enabling targeted investment – Portuguese Iberis Capital becomes a new institutional investor
We are very pleased that the Portuguese investor Iberis Capital has invested 2.2 million euros in our company. …
10. March 2022
Eurox Pharma wants to expand its evidence base and ensure patient-friendly care…
28. January 2022
Last year was the year of megarounds for cannabis startups…
27. January 2022
Eurox Pharma, a company specializing in standardized cannabis extracts and the active ingredient dronabinol, based in Bensheim, …
30. December 2021
The German company Eurox Pharma relies on evidence and production from a single source …
3. December 2021
Published in the Medical Tribune.
2. November 2021
Sales of Δ9-THC represents a new revenue stream for Eurox, which follows the distribution agreement of Eurox’s full-spectrum extracts…
11. October 2021
Royal Society of Medicine: Pain and cannabis medicines conference – everything you wanted to know but were too afraid to ask
Experts in the field of medical cannabis, including Eurox Group’s very own Mike Kindrat present at the Royal Society of Medicine.
6. September 2021
Neil Smith, 56, is the chairman of Germany-based firm Eurox Pharma and CEO of the Integro Medical Clinic.
For further information and interviews/comments please contact our press office, +49 30 40817037 | email@example.com.